JohnRobertBakerMD

Neurology • Batesville, AR

Physician

Join to view full profile

Are you Dr. Baker?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 40 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
409 Virginia Dr
Batesville, AR 72501
Phone+1 870-793-5356

Fax+1 870-793-7017
Is this information wrong?

Summary

Dr. John Baker, MD is a board certified neurologist in Batesville, Arkansas. He is currently licensed to practice medicine in Arkansas. He is affiliated with White River Health.

Education & Training

University of Arkansas for Medical Sciences (UAMS) College of MedicineInternship, Transitional Year, 1976 - 1977
University of Arkansas For Medical Sciences College of MedicineClass of 1976

Certifications & Licensure

AR State Medical License 1976 - 2025
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Action pattern and substrate specificity of the hyaluronan lyase from group B streptococci.
Baker JR, Pritchard DG> ;Biochem. J.. 2000-06-01
Oligomeric forms of the 148 kDa cartilage matrix protein.
Zeineldin R, Ekborg S, Baker J> ;Biochem. J.. 1997-12-01
Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease.
Nuovo JA, Baker JR, Wartofsky L, Lukes YG, Burman KD> ;Diabetes. 1988-03-01
Fructosamine in diabetic pregnancy.
Roberts AB, Baker JR, Court DJ, James AG, Henley P, Ronayne ID> ;Lancet. 1983-10-29
Intra-arterial stroke thrombolysis and carotid stenting: methods for the treatment of ischemic cerebrovascular disease.
Frerichs, K., Baker, J., Norbash, A.> ;Semin Roentgenol. 2002 Oct
Ethnic differences in Type 2 diabetes care and outcomes in Auckland: a multiethnic community in New Zealand.
Robinson, T., Simmons, D., Scott, D., Howard, E., Pickering, K., Cutfield, R., Baker, J., Patel, A., Wellingham, J., Morton, S.> ;N Z Med J. 2006
Timing of symptomatic vasospasm in aneurysmal subarachnoid hemorrhage: the effect of treatment modality and clinical implications.
Ionita, C. C., Baker, J., Graffagnino, C., Alexander, M. J., Friedman, A. H., Zaidat, O. O.> ;J Stroke Cerebrovasc Dis. 2010 Mar
Cleavage specificity of Enterococcus faecalis EnpA (EF1473), a peptidoglycan endopeptidase related to the LytM/lysostaphin family of metallopeptidases.
de Roca, F. R., Duché, C., Dong, S., Rincé, A., Dubost, L., Pritchard, D. G., Baker, J. R., Arthur, M., Mesnage, S.> ;J Mol Biol. 2010 May 14
Hallucinogens and redemption.
de Rios, M. D., Grob, C. S., Baker, J. R.> ;J Psychoactive Drugs. 2002 Jul 01
The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A.
Baker, J. R., Dong, S., Pritchard, D. G.> ;Biochem J. 2002 Jul 1
Achieving normothermia in patients with febrile subarachnoid hemorrhage: feasibility and safety of a novel intravascular cooling catheter.
Badjatia, N., O'Donnell, J., Baker, J. R., Huang, D., Ayata, C., Greer, D. M., Carter, B. S., Ogilvy, C. S., McDonald, C. T.> ;Neurocrit Care. 2004
Psychedelic sacraments.
Baker, J. R.> ;J Psychoactive Drugs. 2005 Jun
Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons...
Cooper, G. J., Chan, Y. K., Dissanayake, A. M., Leahy, F. E., Keogh, G. F., Frampton, C. M., Gamble, G. D., Brunton, D. H., Baker, J. R., Poppitt, S. D.> ;Diabetes. 2005 May
Relationships between polychlorinated biphenyls and health status in harbor porpoises (Phocoena phocoena) stranded in the United Kingdom.
Jepson, P. D., Bennett, P. M., Deaville, R., Allchin, C. R., Baker, J. R., Law, R. J.> ;Environ Toxicol Chem. 2005 Jan
Regeneration of the heart in diabetes by selective copper chelation.
Cooper, G. J., Phillips, A. R., Choong, S. Y., Leonard, B. L., Crossman, D. J., Brunton, D. H., Saafi, L., Dissanayake, A. M., Cowan, B. R., Young, A. A., Occleshaw, C...> ;Diabetes. 2004 Sep
The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30.
Pritchard, D. G., Dong, S., Baker, J. R., Engler, J. A.> ;Microbiology (Reading, Engl). 2004 Jul
Epidemiological pattern of tattoo skin disease: a potential general health indicator for cetaceans.
Van Bressem, M. F., Van Waerebeek, K., Aznar, F. J., Raga, J. A., Jepson, P. D., Duignan, P., Deaville, R., Flach, L., Viddi, F., Baker, J. R., Di Beneditto, A. P., Ec...> ;Dis Aquat Org. 2009 Jul 23
LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells.
Becker, S. C., Dong, S., Baker, J. R., Foster-Frey, J., Pritchard, D. G., Donovan, D. M.> ;FEMS Microbiol Lett. 2009 May 01
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.
Rajamani, K., Colman, P. G., Li, L. P., Best, J. D., Voysey, M., D'Emden, M. C., Laakso, M., Baker, J. R., Keech, A. C.> ;Lancet. 2009 May 23
Composition and proposed structure of a water-soluble glycan from the Keumsa Sangwhang Mushroom (Phellinus linteus).
Baker, J. R., Kim, J. S., Park, S. Y.> ;Fitoterapia. 2008 Jul
LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae.
Pritchard, D. G., Dong, S., Kirk, M. C., Cartee, R. T., Baker, J. R.> ;Appl Environ Microbiol. 2007 Nov
Modulation of glycosaminoglycan levels in tree shrew sclera during lens-induced myopia development and recovery.
Moring, A. G., Baker, J. R., Norton, T. T.> ;Invest Ophthalmol Vis Sci. 2007 Jul
Endopeptidase and glycosidase activities of the bacteriophage B30 lysin.
Baker, J. R., Liu, C., Dong, S., Pritchard, D. G.> ;Appl Environ Microbiol. 2006 Oct
Join now to see all

Hospital Affiliations

White River HealthBatesville, Arkansas